Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Cheng, Hsiao Ling ^a   Su, Shu Jem ^b   Huang, Li Wen ^c   Hsieh, Bau Shan ^a   Hu, Yu Chen ^a   Hung, Thu Ching ^a   Chang, Kee Lung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS RELATED PROTEIN; ARECOLINE; BETA1 INTEGRIN; CASPASE 3; CELL PROTEIN; CYTOCHROME C; INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN INHIBITOR; PROTEIN P190RHOGAP; PROTEIN ROCK; PROTEIN TYROSINE PHOSPHATASE SHP 2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANOIKIS; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRUCTURE; CELL SURFACE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; LIVER CELL; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL ADHESION; CELL SEPARATION; DNA FRAGMENTATION; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; WESTERN BLOTTING;

RATTUS;

ANIMALS; ANOIKIS; ANTINEOPLASTIC AGENTS; ARECOLINE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; CELL SEPARATION; DNA FRAGMENTATION; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN SITU NICK-END LABELING; LIVER NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 77952711940     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-126     Document Type: Article

References (54)

1. Gray JA, Enz A, Spiegel R. Muscarinic agonists for senile dementia: past experience and future trends. Trends Pharmacol Sci 1989, (Suppl):85-88.
2. Raffaele KC, Berardi A, Asthana S, Morris P, Haxby JV, Soncrant TT. Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type. Psychopharmacol Bull 1991, 27:315-319.
3. Chang MC, Wu HL, Lee JJ, Lee PH, Chang HH, Hahn LJ, Lin BR, Chen YJ, Jeng JH. The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem 2004, 279:50676-50683. 10.1074/jbc.M404465200, 15375172.
4. Jeng JH, Wang YJ, Chiang BL, Lee PH, Chan CP, Ho YS, Wang TM, Lee JJ, Hahn LJ, Chang MC. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis 2003, 24:1301-1315. 10.1093/carcin/bgg083, 12807728.
5. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124:619-626. 10.1083/jcb.124.4.619, 2119917, 8106557.
6. Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997, 9:701-706. 10.1016/S0955-0674(97)80124-X, 9330874.
7. Schlessinger K, Levy DE. Malignant transformation but not normal cell growth depends on signal transducer and activator of transcription 3. Cancer Res 2005, 65:5828-5834. 10.1158/0008-5472.CAN-05-0317, 2100417, 15994959.
8. Ma Z, Myers DP, Wu RF, Nwariaku FE, Terada LS. p66Shc mediates anoikis through RhoA. J Cell Biol 2007, 179:23-31. 10.1083/jcb.200706097, 2064727, 17908916.
9. Arthur WT, Burridge K. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 2001, 12:2711-2720. 59706, 11553710.
10. Brouns MR, Matheson SF, Settleman J. p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation. Nat Cell Biol 2001, 3:361-367. 10.1038/35070042, 11283609.
11. Maddox AS, Burridge K. RhoA is required for cortical retraction and rigidity during mitotic cell rounding. J Cell Biol 2003, 160:255-265. 10.1083/jcb.200207130, 2172639, 12538643.
12. Neel BG, Gu H, Pao L. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 2003, 28:284-293. 10.1016/S0968-0004(03)00091-4, 12826400.
13. Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 2006, 1091:151-169. 10.1196/annals.1378.063, 17341611.
14. Chen CL, Cen L, Kohout J, Hutzen B, Chan C, Hsieh FC, Loy A, Huang V, Cheng G, Lin J. Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Mol Cancer 2008, 7:78. 10.1186/1476-4598-7-78, 2577686, 18939995.
15. Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Avila MA. Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci 2009, 1155:206-221. 10.1111/j.1749-6632.2009.03704.x, 19250206.
16. Gao B. Cytokines, STATs and liver disease. Cell Mol Immunol 2005, 2:92-100.
17. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001, 28:29-35. 10.1038/88225, 11326271.
18. Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo J, Thompson JA, Schraven BL, Philips MR, Neel BG. Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell 2004, 13:341-355. 10.1016/S1097-2765(04)00050-4, 14967142.
19. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 2001, 3:339-345. 10.1038/35070009, 11283606.
20. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997, 15:797-819. 10.1146/annurev.immunol.15.1.797, 9143707.
21. Yang SF, Wang SN, Wu CF, Yeh YT, Chai CY, Chunag SC, Sheen MC, Lee KT. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma. J Clin Pathol 2007, 60:642-648. 10.1136/jcp.2006.036970, 1955084, 16901975.
22. Grivennikov S, Karin M. Autocrine IL-6 signaling: a key event in tumorigenesis?. Cancer Cell 2008, 13:7-9. 10.1016/j.ccr.2007.12.020, 18167335.
23. Chandra JN, Malviya M, Sadashiva CT, Subhash MN, Rangappa KS. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models. Neurochem Int 2008, 52:376-383. 10.1016/j.neuint.2007.07.006, 17719699.
24. Xie DP, Chen LB, Liu CY, Zhang CL, Liu KJ, Wang PS. Arecoline excites the colonic smooth muscle motility via M3 receptor in rabbits. Chin J Physiol 2004, 47:89-94.
25. Yang YR, Chang KC, Chen CL, Chiu TH. Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor. Chin J Physiol 2000, 43:23-28.
26. Vatamaniuk MZ, Horyn OV, Vatamaniuk OK, Doliba NM. Acetylcholine affects rat liver metabolism via type 3 muscarinic receptors in hepatocytes. Life Sci 2003, 72:1871-1882. 10.1016/S0024-3205(02)02506-7, 12586224.
27. Burdon D, Patel R, Challiss RA, Blank JL. Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest. Biochem J 2002, 367:549-559. 10.1042/BJ20020446, 1222904, 12126481.
28. Nicke B, Detjen K, Logsdon CD. Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells. J Biol Chem 1999, 274:21701-21706. 10.1074/jbc.274.31.21701, 10419481.
29. Strassheim D, May LG, Varker KA, Puhl HL, Phelps SH, Porter RA, Aronstam RS, Noti JD, Williams CL. M3 muscarinic acetylcholine receptors regulate cytoplasmic myosin by a process involving RhoA and requiring conventional protein kinase C isoforms. J Biol Chem 1999, 274:18675-18685. 10.1074/jbc.274.26.18675, 10373480.
30. Del Re DP, Miyamoto S, Brown JH. RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem 2007, 282:8069-8078. 10.1074/jbc.M604298200, 17234627.
31. Sebbagh M, Renvoize C, Hamelin J, Riche N, Bertoglio J, Breard J. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol 2001, 3:346-352. 10.1038/35070019, 11283607.
32. Van Aelst L, D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev 1997, 11:2295-2322. 10.1101/gad.11.18.2295, 9308960.
33. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE. Stat3 as an oncogene. Cell 1999, 98:295-303. 10.1016/S0092-8674(00)81959-5, 10458605.
34. Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, Guan KL. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 2000, 290:144-147. 10.1126/science.290.5489.144, 11021801.
35. Faruqi TR, Gomez D, Bustelo XR, Bar-Sagi D, Reich NC. Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci USA 2001, 98:9014-9019. 10.1073/pnas.161281298, 55365, 11470914.
36. Aznar S, Valeron PF, del Rincon SV, Perez LF, Perona R, Lacal JC. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Mol Biol Cell 2001, 12:3282-3294. 60173, 11598209.
37. Debidda M, Wang L, Zang H, Poli V, Zheng Y. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J Biol Chem 2005, 280:17275-17285. 10.1074/jbc.M413187200, 15705584.
38. Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, Ponchel F, Yakicier C, Ji J, Ozturk M. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J 1993, 7:1407-1413.
39. Gadea G, de Toledo M, Anguille C, Roux P. Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J Cell Biol 2007, 178:23-30. 10.1083/jcb.200701120, 2064414, 17606864.
40. Xia M, Land H. Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat Struct Mol Biol 2007, 14:215-223. 10.1038/nsmb1208, 17310253.
41. Karni R, Jove R, Levitzki A. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene 1999, 18:4654-4662. 10.1038/sj.onc.1202835, 10467412.
42. Dave BJ, Trivedi AH, Adhvaryu SG. In vitro genotoxic effects of areca nut extract and arecoline. J Cancer Res Clin Oncol 1992, 118:283-288. 10.1007/BF01208617, 1577847.
43. Sharan RN, Wary KK. Study of unscheduled DNA synthesis following exposure of human cells to arecoline and extracts of betel nut in vitro. Mutat Res 1992, 278:271-276. 10.1016/S0165-1218(10)80007-2, 1373864.
44. Shirname LP, Menon MM, Bhide SV. Mutagenicity of betel quid and its ingredients using mammalian test systems. Carcinogenesis 1984, 5:501-503. 10.1093/carcin/5.4.501, 6705148.
45. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004, 85:1-334.
46. Jeng JH, Kuo ML, Hahn LJ, Kuo MY. Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J Dent Res 1994, 73:1043-1049.
47. Jeng JH, Tsai CL, Hahn LJ, Yang PJ, Kuo YS, Kuo MY. Arecoline cytotoxicity on human oral mucosal fibroblasts related to cellular thiol and esterase activities. Food Chem Toxicol 1999, 37:751-756. 10.1016/S0278-6915(99)00050-2, 10496377.
48. Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Grafstrom RC. Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res 1989, 49:5294-5298.
49. Lee PH, Chang MC, Chang WH, Wang TM, Wang YJ, Hahn LJ, Ho YS, Lin CY, Jeng JH. Prolonged exposure to arecoline arrested human KB epithelial cell growth: regulatory mechanisms of cell cycle and apoptosis. Toxicology 2006, 220:81-89. 10.1016/j.tox.2005.07.026, 16413651.
50. Devirgiliis LC, Dini L, Di Pierro A, Leoni S, Spagnuolo S, Stefanini S. An improved non-perfusion method for the isolation and purification of rat foetal and neonatal hepatocytes. Cell Mol Biol 1981, 27:687-694.
51. Belloc F, Belaud-Rotureau MA, Lavignolle V, Bascans E, Braz-Pereira E, Durrieu F, Lacombe F. Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells. Cytometry 2000, 40:151-160. 10.1002/(SICI)1097-0320(20000601)40:2<151::AID-CYTO9>3.0.CO;2-9, 10805935.
52. McGill G, Shimamura A, Bates RC, Savage RE, Fisher DE. Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol 1997, 138:901-911. 10.1083/jcb.138.4.901, 2138041, 9265655.
53. Su SJ, Chow NH, Kung ML, Hung TC, Chang KL. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer 2003, 45:113-123. 10.1207/S15327914NC4501_13, 12791511.
54. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.